Photodynamic therapy of microbial infections: State of the art and perspectives

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 25, Issue 1-2, 2006, Pages 505-519

  Jori, Giulio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Activated oxygen; Antibiotic resistance; Bacteria; Fungi; Microbial infections; Photodynamic therapy; Photosensitization; Phthalocyanines; Porphyrins

Indexed keywords

AMINOLEVULINIC ACID; BETA LACTAM; HEMIN; METHYLENE BLUE; PHENOTHIAZINE DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; PHTHALOCYANINE DERIVATIVE; PORPHYRIN; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; TETRAKIS(N METHYLPYRIDYL)PORPHINE; UNCLASSIFIED DRUG;

CHRONIC WOUND; CONCENTRATION (PARAMETERS); DIFFUSION; HUMAN; INFECTION; LIGHT ABSORPTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROORGANISM; MYCOPLASMA; MYCOSIS; NONHUMAN; PERIODONTITIS; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PRIORITY JOURNAL; REVIEW; THRUSH;

FUNGI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOPLASMA;

EID: 33644770428     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.320     Document Type: Review

References (60)

1. Patrice TJ. Photodynamic therapy. Cambridge: Royal Society of Chemistry, 2003.
2. Hamblin MR, Ortel B. Future directions - photosensitizer targeting and new disease indications. In: Calzavara PG, Szeimies RM, Ortel B, Editors. Photodynamic therapy and fluorescence diagnosis in dermatology. Amsterdam: Elsevier, 2001; 339-366.
3. Tunger O, Dinc G, Ozbakkaloglu B, Atman C, Algun U. Evaluation of rational antibiotic use. Int J Antimicrob Agents 2000; 15:131-135.
4. Jori G. Photodynamische therapiemin der mikorobiologie. In: Szeimies RM, Jocham D, Landthaler M, editors. Klinische Fluoreszenzdiagnostik und Photodynamische Therapie. Berlin: Blackwell Verlag 2003; 360-371.
5. Jori G, Spikes JD. Photobiochemistry of porphyrins. In: Smith KC, Editor. Topics in photomedicine. New York: Plenum Press, 1984; 183-319.
6. Polo L, Valduga G, Jori G, Reddi E. Low density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts. Int J Biochem Cell Biol 2002; 34:10-23.
7. Soncin M, Fabris C, Busetti A, Dei D, Nistri D, Roncucci G, Jori G. Approaches to selectivity in the Zn(II)-phthalocyanine- photosensitized inactivation of wild-type and antibiotic-resistant Staphylococcus aureus. Photochem Photobiol Sci 2002; 1:815-819.
8. Svaasand LO. Optical properties of human brain. Photochem Photobiol 1984; 38:293-299.
9. Wainwright M. Photodynamic antimicrobial chemotherapy. J Antimicrob Chemother 1998; 42:13-28.
10. Salmon-Divon M, Nitzan Y, Malik Z. Mechanistic aspects of Escherichia coli photodynamic inactivation by cationic tetrameso(N-methylpyridyl)porphine. Photochem Photobiol Sci 2004; 3:423-429.
11. Merchat M, Bertoloni G, Giacomoni P, Villanueva A, Jori G. Meso-substituted cationic porphyrins as efficient photosensitisers of Gram-positive and Gram-negative bacteria. J Photochem Photobiol B: Biol 1996; 32:153-157.
12. Malik Z, Ladan H, Nitzan Y. Photodynamic inactivation of Gram-negative bacteria: problems and possible solutions. J Photochem Photobiol B: Biol 1992; 14:261-266.
13. Merchat M, Spikes JD, Bertoloni G, Jori G. Studies on the mechanism of bacteria photosensitisation by meso-substituted cationic porphyrins. J Photochem Photobiol B: Biol 1992; 36:149-157.
14. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumors. J Photochem Photobiol B: Biol 1997; 39:1-18.
15. Nitzan Y, Gutterman M, Malik Z, Ehrenberg B. Inactivation of Gram-negative bacteria by photosensitized porphyrins. Photochem Photobiol 1992; 55:89-96.
16. Valduga G, Breda B, Giacometti GM, Jori G, Reddi E. Photosensitization of wild and mutant strains of Escherichia coli by mesotetra(N-methyl-4-pyridyl) porphine. Biochem Biophys Res Commun 1999; 256:84-88.
17. Nitzan Y, Balzam-Sudakevitz A, Ashkenzai H. Eradication of Acinetobacter baumannii by photosensitized agents in vitro. J Photochem Photobiol B: Biol 1998; 42:211-218.
18. Schafer M, Schmitz C, Horneck G. High sensitivity of Deinococcus radiodurans to photodynamically produced singlet oxygen. Int J Radiat Biol 1998; 74:249-253.
19. Paardekooper M, Van Gompel AE, Van Steveninck J, Van den Broek PJ. The effect of photodynamic treatment of yeast with the sensitizer chloroaluminum phthalocyanine on various cell parameters. Photochem Photobiol 1995; 62:561-567.
20. Lazarova G. Effect of glutathione on rose bengal photosensitized yeast damage. Microbios 1993; 75:39-43.
21. Segalla A, Borsarelli CD, Braslavsky SE, Spikes JD, Roncucci G, Dei D, Chiti G, Jori G, Reddi E. Photophysical, photochemical and antibacterial photosensitizing properties of a novel octacationic Zn(II)-phthalocyanine. Photochem Photobiol Sci 2002; 1:641-648,
22. Zeina B, Greenman J, Purcell WM, Das B. Killing of cutaneous microbial species by photodynamic therapy. Br J Dermatol 2001; 144:274-278.
23. Soukos NS, Wilson M, Burns T, Speight PM. Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguinis evaluated in vitro. Lasers Surg Med 1996; 18;253-259.
24. Jori G, Brown SB. Photosensitized inactivation of microorganisms. Photochem Photobiol Sci 2004; 3:403-405.
25. Bertoloni G, Reddi E, Gatta M, Burlini C, Jori G. Factors influencing the hematoporphyrin-sensitized photoinactivation of Candida albicans. J Gen Microbiol 1989; 135:957-966.
26. Maisch T, Szeimies RM, Jori G, Abels C. Antibacterial photodynamic therapy in dermatology. Photochem Photobiol Sci 2004; 3:907-917.
27. Minnock A, Vernon DI, Schofield J, Griffiths J, Parish JH, Brown SB. Photoinactivation of bacteria. Use of a cationic water-soluble zinc-phthalocyanine to photoinactivate both Gram-negative and Gram-positive bacteria. J Photochem Photobiol B: Biol 1996; 32:159-164.
28. Dougherty TJ, Gomer CJ, Henderson B, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998; 90:889-905.
29. 6 conjugates. Photochem Photobiol 1997; 65:723-729.
30. Polo L, Segalla A, Bertoloni G, Jori G, Schaffner K, Reddi E. Polylysine-porphycene conjugates as efficient photosensitizers for the inactivation of microbial pathogens. J Photochem Photobiol B:Biol 2000; 59:152-158.
31. Lauro F, Pretto P, Covolo L, Jori G, Bertoloni G. Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates. Photochem Photobiol Sci 2002; 1:468-470.
32. Rovaldi CR, Pievsky A, Sole NA, Friden PM, Rothstein DM, Spacciapoli P. Photoactive porphyrin derivative with broad-spectrum activity against oral pathogens in vitro. Antimicrob Agents Chemother 2000; 44:3364-3367.
33. Hamblin MR, O'Donnell DA, Murthy N, Rajagopalan K, Michaud N, Sherwood ME, Hasan T. Polycationic photosensitiser conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria. J Antimicrob Chemother 2002; 49:941-951.
34. Henry CA, Judy M, Dyer B, Wagner M,Mathhews JL. Sensitivity of Porphyromonas and Prevotella species in liquid media to argon laser. Photochem Photobiol 1995; 61:410-413.
35. Meffert H, Gaunitz K, Gutewort T, Amlong UJ. Therapy of acne with visible light. Decreased irradiation time by using a blue light high energy lamp. Dermatol Monatsschr 1990; 176:597-600.
36. Gabor F, Szocs K, Maillard P, Csik G. Photobiological activity of exogenous and endogenous porphyrin derivatives in Escherichia coli and Enterococcus hirae cells. Radiat Environ Biophys 2001; 40:145-151.
37. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM. 5-Aminolevulinc acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997; 79:2282-2308.
38. Hamblin MR, Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci 2004; 3:436-450.
39. Berthiaume F, Reiken S, Toner M, Tompkins R, Yarmush M. Antibody-targeted photolysis of bacteria in vivo. Biotechnology 1994; 12:703-706.
40. Orenstein A, Klein D, Kopolovic J, Winkler E, Malik Z, Keller N, Nitzan Y. The use of porphyrin for the eradication of Staphylococcus aureus in burn wound infections. FEMS Immunol Med Microbiol 1997; 19:307-314.
41. Millson CE, Wilson M, McRobert AJ, Bown SG. Ex-vivo treatment of gastric Helicobacter infection by photodynamic therapy. J Photochem Photobiol B Biol 1996; 32:59-65.
42. Wood S, Nattress B, Kirkham J, Shore R, Brookers S, Griffith J, Robinson C. An in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilms formed in vivo. J Photochem Photobiol B Biol 1999; 50:1-7.
43. Lasocki K, Szpakowska M, Grzybowski J, Graczyk A. Examination of antibacterial activity of the photoactivated arginine-haematoporphyrin derivative. Pharmacol Res 1999; 39:181-184.
44. Chambers HF. The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis 2001; 7:178-182.
45. European Antimicrobial Resistance Surveillance System (EARSS). EARSS Annual Report 2002, Bilthoven, The Netherlands.
46. Chambers HF. Methicillin-resistance in staphylococci: molecular and biochemical basis and clinical implications. Microbiol Rev 1997; 10:781-791.
47. Cristomo MI, Westh H, Tomasz A, Chung M, Oliveira DC, de Lancastre H. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci U S A 2001; 98:9865-9870.
48. Lutz L, Machado M, Kuplich N, Barth AL. Clinical failure of vancomycin treatment of Staphylococcus aureus infection in a tertiary care hospital. Braz J Infect Dis 2003; 7:224-228.
49. Malik Z, Gozhansky S, Nitzan Y. Effects of photoactivated haematoporphyrin derivative on bacteria and antibiotic resistance. Microbios Lett 1982; 21:103-112.
50. Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol. 1998; 139:13-16.
51. Aly R, Maibach I, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol 1977; 113:780-782.
52. Zeina B, Greenman J, Corry D, Purcell WM. Cytotoxic effects of antimicrobial photodynamic therapy on keratinocytes in vitro. Br J Dermatol 2002; 146:568-573.
53. Itoh Y, Ninomyia Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta-aminolevulinic acid. Br J Dermatol 2001 144:575-579.
54. Ashkenazi H, Malik Z, Harth Y, Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immun Med Microbiol 2003; 35:17-24.
55. Berger TG. Treatment of bacterial, fungal and parasitic infections in the HIV-infected host. Semin Dermatol 1993; 12:296-300.
56. Wilson M, Dobson J. Lethal photosensitization of oral anaerobic bacteria. Clin Infect Dis 1993; 16:414-417.
57. Wilson M. Susceptibility of oral bacterial biofilms to antimicrobial agents. J Med Microbiol 1996; 44:79-87.
58. Wilson M. Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infections. Photochem Photobiol Sci 2004; 3:412-418.
59. Gad F, Zahra T, Francis KP, Hasan T, Hamblin MR. Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci 2004; 3:451-458.
60. Alouini Z, Jemli M. Destruction of helminth eggs by photosensitized porphyrin. J Environ Monit 2001; 3:548-551.